Paradigm Biocapital Advisors LP 13D and 13G filings for Alpine Immune Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:08 pm Purchase | 2023-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN | Paradigm Biocapital Advisors LP | 3,176,743 5.500% | 859,109 (+37.07%) | Filing |
| 2023-02-14 4:58 pm Purchase | 2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN | Paradigm Biocapital Advisors LP | 2,317,634 5.050% | 102,912 (+4.65%) | Filing |
| 2022-10-03 5:16 pm Purchase | 2022-09-23 | 13G | Alpine Immune Sciences, Inc. ALPN | Paradigm Biocapital Advisors LP | 2,214,722 5.030% | 2,214,722 (New Position) | Filing |